Clinical Trials Browser

Phase 1/2 × Waldenstrom Macroglobulinemia × Magnetic Resonance Spectroscopy × Clear all

NCT07420959 2026-02-19

ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia

Phase 1/2 Not yet recruiting

Waldenstrom Macroglobulinemia